STZ is an agent of choice to induce experimental diabetes mellitus due to its ability to induce specific necrosis of the pancreatic beta cells that results in degranulation and loss of capacity to secrete insulin [33], thereby leading to hyperglycemia and diabetic complications such as nephropathy [32]. The gene discussed is INS; the disease is Hyperglycemia.